All Articles

Fintech innovator Capitolis is set to acquire a 15-year-old U.S. secured financing platform, a strategic move to expand its Capital Marketplace.

Despite a reported net loss, the REIT saw a 162% jump in key operational funds and a 22% surge in its senior housing portfolio's income.

An Orlando startup is using AI for 10-second quotes and escrow payments, aiming to fix a market plagued by delays and a severe skilled labor shortage.

India's largest newspaper group wins a top CSR award, but it's the citizen-led campaigns behind the win that reveal a new model for media's social impact.

New data reveals a targeted therapy can help patients with a rare, aggressive lung cancer even after their disease shows signs of worsening.

With AI expert Zack Kass headlining, Scale Computing's upcoming summit aims to redefine edge infrastructure, challenging traditional distributed IT models.

A new $175M Indiana facility from a Kratos-RAFAEL venture breaks ground, aiming to fix a critical national security vulnerability in U.S. rocket motor production.

After a disastrous quarter sends shares tumbling 18%, activist investor Biglari Capital calls for the ouster of Chairman David Goebel, igniting a battle.

With most enterprise AI projects failing, TQA expands its partnerships with Microsoft and ServiceNow to move AI from experimentation to real-world impact.

With its NAD+ technology featured in Forbes, biotech brand Aramore is challenging marketing hype with scientific rigor and a vision for longevity.

A new virotherapy platform delivers a one-two punch of a T-cell activator and a BiTE, aiming to overcome historical failures in solid tumor therapy.

BitGo and New Frontier Labs are launching FYUSD, a stablecoin bringing U.S. regulatory standards to Asia and paving the way for AI-driven finance.

As MARA preps its Q4 earnings call, investors look beyond Bitcoin to see if its ambitious digital energy and AI infrastructure strategy is paying off.

As Home Instead names its 10 Care Pros of the Year, the awards highlight both profound human compassion and the urgent need to address a critical caregiver shortage.

Singapore's Strutt Inc. sees unprecedented demand for its ev¹ Smart Everyday Vehicle. Now, the company faces the ultimate test: scaling up to deliver.

After a period of uncertainty, the digital asset firm has regained compliance with Nasdaq's bid price rule, a key step for its institutional ambitions.

ABLi Therapeutics reports its drug risvodetinib is the first to lower toxic alpha-synuclein levels in a Phase 2 trial, heralding a new era for patients.

enGene hits the road for key investor conferences, showcasing a promising non-viral gene therapy for a tough-to-treat bladder cancer. Will it succeed?

With a 10x surge in transaction volume, Pay Protocol's success on TRON highlights a quiet revolution in business finance, powered by stablecoins.

F&G Annuities & Life declared its quarterly dividend, offering a sign of stability even as a recent earnings report and stock drop raise questions.